Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. Centre Hospitalier Universitaire, Amiens, France



Survival: 6.2 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: France
   
City/State/Province: Amiens
   
Hospital: Centre Hospitalier Universitaire
   
Journal: Link
   
Date: 10/2012

Description:
Patients:
This phase 2 study involved 60 T cell lymphoma patients whose cancer had progressed after prior chemotherapy. The median patient age was 66 years and 38 patients were male.

Treatment:
Patients were treated with the chemotherapy agent bendamustine.

Toxicities:
There were 4 reported deaths due to infection. Grade 3-4 neutropenia, inflammation of the lining of the GI tract (mucositis), and thrombocytopenia were also reported.

Results:
The median progression-free survival was 3.6 months and the median overall survival was 6.2 months.

Support:
This study was supported by Mundipharma, Roche, and Chugai, which are pharmaceutical companies.

Correspondence: Dr. Gandhi Damaj; email: damaj.gandhi@chu-amiens.fr

E-mail to a Friend Email Physician More Information